Remus Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
No Data Available
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 63.50 | 45.03 | 24.72 |
| Operating Expenses Annual | 43.45 | 34.48 | 20.58 |
| Operating Profit Annual | 23.74 | 12.12 | 4.86 |
| Interest Annual | 0.32 | 0.23 | 0.09 |
| Depreciation | 0.90 | 0.48 | 0.15 |
| Net Profit Annual | 16.82 | 8.50 | 3.43 |
| Tax Annual | 5.71 | 2.91 | 1.18 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 63.50 |
| Operating Expenses Annual | 43.45 |
| Operating Profit Annual | 23.74 |
| Interest Annual | 0.32 |
| Depreciation | 0.90 |
| Net Profit Annual | 16.82 |
| Tax Annual | 5.71 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 3.04 | 1.15 | 0.83 |
| Cash Flow from Operations | 2.43 | 5.31 | 5.04 |
| Cash Flow from Investing | -20.90 | -15.19 | -4.55 |
| Cash Flow from Financing | 39.29 | 11.77 | -0.17 |
| Cash Flow at the End | 23.85 | 3.04 | 1.15 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 3.04 |
| Cash Flow from Operations | 2.43 |
| Cash Flow from Investing | -20.90 |
| Cash Flow from Financing | 39.29 |
| Cash Flow at the End | 23.85 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 37.39 | 26.92 | 19.66 |
| PBIT Margin (%) | 35.97 | 25.85 | 19.05 |
| PBT Margin (%) | -76.49 | -86.54 | -192.20 |
| Net PROFIT Margin (%) | 26.49 | 18.88 | 13.88 |
| Return On Networth / Equity (%) | 33.24 | 66.10 | 70.58 |
| Return On Networth /Employed (%) | 41.05 | 68.21 | 92.25 |
| Return On Assets (%) | 30.20 | 49.83 | 67.30 |
| Total Debt / Equity (X) | 0.09 | 0.32 | 0.05 |
| Asset Turnover Ratio (%) | 1.14 | 2.64 | 4.85 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 37.39 |
| PBIT Margin (%) | 35.97 |
| PBT Margin (%) | -76.49 |
| Net PROFIT Margin (%) | 26.49 |
| Return On Networth / Equity (%) | 33.24 |
| Return On Networth /Employed (%) | 41.05 |
| Return On Assets (%) | 30.20 |
| Total Debt / Equity (X) | 0.09 |
| Asset Turnover Ratio (%) | 1.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 2.29 | 2.54 | 0.31 |
| Total Current Assets Annual | 51.16 | 11.34 | 7.69 |
| Non Current Assets Annual | 46.90 | 23.32 | 8.17 |
| Total Shareholders Funds Annual | 82.06 | 19.14 | 6.58 |
| Total Assets Annual | 98.05 | 34.66 | 15.86 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 2.29 |
| Total Current Assets Annual | 51.16 |
| Non Current Assets Annual | 46.90 |
| Total Shareholders Funds Annual | 82.06 |
| Total Assets Annual | 98.05 |
No Data Availabe
